Faiqa Falak Naz

Dr. Faiqa Falak Naz


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2022 in Polymers
Verified
Journal Article
Open access
PDF file
FNFaiqa Falak Naz
Faiqa Falak Naz
KSKifayat Ullah Shah
Kifayat Ullah Shah
ZNZahid Rasul Niazi
Zahid Rasul Niazi
MZMansoor Zaman
Mansoor Zaman
VLVuanghao Lim
Vuanghao Lim
MAMulham Alfatama
Mulham Alfatama
Rifampicin, a potent broad-spectrum antibiotic, remains the backbone of anti-tubercular therapy. However, it can cause severe hepatotoxicity when given orally. To overcome the limitations of the current oral therapy, this study designed inhalable spray-dried, rifampicin-loaded microparticles using aloe vera powder as an immune modulator, with varying concentrations of alginate and L-leucine. The microparticles were assessed for their physicochemical properties, in vitro drug release and aerodynamic behavior. The spray-dried powders were 2 to 4 µm in size with a percentage yield of 45 to 65%. The particles were nearly spherical with the tendency of agglomeration as depicted from Carr’s index (37 to 65) and Hausner’s ratios (>1.50). The drug content ranged from 0.24 to 0.39 mg/mg, with an association efficiency of 39.28 to 96.15%. The dissolution data depicts that the in vitro release of rifampicin from microparticles was significantly retarded with a higher L-leucine concentration in comparison to those formulations containing a higher sodium alginate concentration due to its hydrophobic nature. The aerodynamic data depicts that 60 to 70% of the aerosol mass was emitted from an inhaler with MMAD values of 1.44 to 1.60 µm and FPF of 43.22 to 55.70%. The higher FPF values with retarded in vitro release could allow sufficient time for the phagocytosis of synthesized microparticles by alveolar macrophages, thereby leading to the eradication of M. tuberculosis from these cells.

2 September 2023 in Journal of Pharmaceutical Innovation
Verified
Journal Article
Closed access
PDF file
HRHabib Ur Rehman
Habib Ur Rehman
MSMuhammad Danish Saeed
Muhammad Danish Saeed
FUFaqir Ullah
Faqir Ullah
FNFaiqa Falak Naz
Faiqa Falak Naz
KKKamran Ahmad Khan
Kamran Ahmad Khan
KSKifayat Ullah Shah
Kifayat Ullah Shah

23 May 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
RARasikha Akbar
Rasikha Akbar
DKDildar Khan
Dildar Khan
MSMuhammad Bilal Sabir
Muhammad Bilal Sabir
DSDr Irfan SHAUKAT
Dr Irfan SHAUKAT
IRIrfa Basharat Rajpoot
Irfa Basharat Rajpoot
KSKifayat Ullah Shah
Kifayat Ullah Shah
The aim of the current study was to develop and evaluate the therapeutic potential of apocynin (APO) loaded pH-sensitive nanoparticles (NPs) based transdermal hydrogel for management of rheumatoid arthritis (RA). Slightly modified nanoprecipitation technique was used for preparation of polymeric nanoparticles. Optimization was done through design expert software. Optimized APO-NPs were loaded into carbopol-934 based hydrogel as final dosage form and further studied for physicochemical properties. Optimized APO-NPs formulation had a minimum particle size 63.44 nm, polydisperibility index 0.161, and zeta potential -15mV with a maximum encapsulation efficiency of 89%. In-vitro and ex-vivo studies of APO-NPs based hydrogel was performed at pH 5.5 (pH of normal skin) and 6.8 (pH of inflammed joint) showed a pH-responsive sustained drug release and increased penetration in comparison to free APO based hydrogel. The stability studies of APO-NPs based hydrogel were done to strengthen the potential use of the prepared formulation through transdermal route. Assessment and therapeutic efficacy of the prepared pH-sensitive nanocarriers system was evaluated in chronic inflammatory RA mice model. Parameters associated with chronic inflammation were investigated including behavioral changes and histopathological, and radiological x-rays images of joints of mice paws. In-vivo study depicts improvement in behavioral parameter, decline in synovial hyperplasia and bone structure restoration. In conclusion, APO loaded pH-sensitive NPs based transdermal is a promising carrier system that can effectively manage RA.